发明名称 Specific binding proteins and uses thereof
摘要 The invention relates to specific binding members, particularly antibodies and active fragments thereof, which recognize an aberrant post-translationally modified, particularly an aberrant glycosylated form of the EGFR. The binding members, particularly antibodies and fragments thereof, of the invention do not bind to EGFR on normal cells in the absence of amplification of the wild-type gene and are capable of binding the de2-7 EGFR at an epitope which is distinct from the junctional peptide. Antibodies of this type are exemplified by the novel antibody 806 whose VH and VL sequences are illustrated as SEQ ID NOs: 2 and 4 and chimeric antibodies thereof as exemplified by ch806.
申请公布号 US9562102(B2) 申请公布日期 2017.02.07
申请号 US201213711368 申请日期 2012.12.11
申请人 Ludwig Institute for Cancer Research 发明人 Old Lloyd J.;Ritter Gerd;Jungbluth Achim;Stockert Elisabeth;Cavenee Webster K.
分类号 C07K16/30;C12N5/20;C07K16/28;A61K39/395;A61K45/06;A61K39/00 主分类号 C07K16/30
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Cowles Cristin H.;Fiala Kevin A.
主权项 1. An isolated antibody produced by hybridoma cell line 806 (ATCC Accession No. PTA-3858).
地址 New York NY US